ISSN: 0213-005X

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Scientific letter

The infectious diseases challenges facing Spain in 2040 require the specialty: A national and international survey

Los retos de las enfermedades infecciosas a los que se enfrenta España en el 2040 requieren la creación de la Especialidad: Resultados de una encuesta nacional e internacional

Jose M. Miroa,b,

Corresponding author

jmmiro@ub.edu

Corresponding author.

, Asuncion Morenoa

a Infectious Diseases Service, Hospital Clinic – IDIBAPS, University of Barcelona, Barcelona, Spain

b CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain

Read

1312

Times
was read the article

330

Total PDF

982

Total HTML

Share statistics

Article information

ISSN: 0213005X
Original language: English

DOI:10.1016/j.eimc.2022.08.009

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	44	5	49
2024 November	30	8	38
2024 October	28	9	37
2024 September	30	20	50
2024 August	24	19	43
2024 July	24	8	32
2024 June	27	17	44
2024 May	17	8	25
2024 April	28	17	45
2024 March	40	14	54
2024 February	27	13	40
2024 January	47	11	58
2023 December	22	8	30
2023 November	29	11	40
2023 October	47	4	51
2023 September	44	9	53
2023 August	28	5	33
2023 July	14	10	24
2023 June	51	3	54
2023 May	62	10	72
2023 April	38	2	40
2023 March	48	6	54
2023 February	41	14	55
2023 January	192	66	258
2022 December	0	3	3
2022 November	0	15	15
2022 October	0	15	15

Show all

Follow this link to access the full text of the article

Publish in

Enfermedades Infecciosas y Microbiología Clínica

La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

Indexed in:

Follow us:

Subscribe:

Statistics

Subscribe to our newsletter